Critical Outcome Technologies Inc. Share Price Toronto S.E.
Equities
COT
CA22675B1031
Biotechnology & Medical Research
End-of-day quote
Other stock markets
|
||
- CAD | - |
|
Sales 2018 | - | Sales 2019 | - | Capitalization | 1.61M 2.2M 124M |
---|---|---|---|---|---|
Net income 2018 | -4M -5.47M -308M | Net income 2019 | -2M -2.74M -154M | EV / Sales 2018 | - |
Net cash position 2018 | 40.73K 55.72K 3.14M | Net cash position 2019 | 24.64K 33.71K 1.9M | EV / Sales 2019 | - |
P/E ratio 2018 |
-1.11
x | P/E ratio 2019 |
-0.6
x | Employees | - |
Yield 2018 * |
-
| Yield 2019 |
-
| Free-Float | 69.18% |
Managers | Title | Age | Since |
---|---|---|---|
Alison D. Silva
PSD | President | 46 | 31/12/14 |
Debi Sanderson
COO | Chief Operating Officer | - | - |
Chief Tech/Sci/R&D Officer | 61 | 11/06/17 |
Members of the board | Title | Age | Since |
---|---|---|---|
Director/Board Member | 63 | 30/06/18 | |
John C. Drake
CHM | Chairman | - | 19/02/07 |
Alison D. Silva
PSD | President | 46 | 31/12/14 |
1st Jan change | Capi. | |
---|---|---|
+20.63% | 127B | |
+25.01% | 27.67B | |
-20.17% | 20.33B | |
-17.26% | 16.79B | |
-18.07% | 15.63B | |
-47.70% | 14.65B | |
+11.92% | 14.84B | |
+58.32% | 14.43B | |
+149.98% | 12.49B |
- Stock Market
- Equities
- COTQF Stock
- COT Stock